CN1678340A - O－衍化诺卡硫星衍生物 - Google Patents

O－衍化诺卡硫星衍生物 Download PDF

Info

Publication number
CN1678340A
CN1678340A CNA038206323A CN03820632A CN1678340A CN 1678340 A CN1678340 A CN 1678340A CN A038206323 A CNA038206323 A CN A038206323A CN 03820632 A CN03820632 A CN 03820632A CN 1678340 A CN1678340 A CN 1678340A
Authority
CN
China
Prior art keywords
alkyl
compound
mmol
formula
nocathiacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038206323A
Other languages
English (en)
Chinese (zh)
Inventor
T·W·胡德马
X·郑
B·N·奈杜
M·E·索伦森
A·雷古伊罗-伦
T·P·康诺利
J·D·马蒂斯科拉
O·K·金
Y·张
D·M·施普林格
J·戈德里奇
Y·尤达
J·J·布龙森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN1678340A publication Critical patent/CN1678340A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA038206323A 2002-07-03 2003-07-02 O－衍化诺卡硫星衍生物 Pending CN1678340A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/189,710 US7022667B2 (en) 2002-07-03 2002-07-03 O-derivatized nocathiacin derivatives
US10/189,710 2002-07-03

Publications (1)

Publication Number Publication Date
CN1678340A true CN1678340A (zh) 2005-10-05

Family

ID=30114034

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038206323A Pending CN1678340A (zh) 2002-07-03 2003-07-02 O－衍化诺卡硫星衍生物

Country Status (9)

Country Link
US (1) US7022667B2 (enExample)
EP (1) EP1531854A4 (enExample)
JP (1) JP2005536492A (enExample)
CN (1) CN1678340A (enExample)
AU (1) AU2003247783A1 (enExample)
BR (1) BR0312550A (enExample)
CA (1) CA2491074A1 (enExample)
MX (1) MXPA05000140A (enExample)
WO (1) WO2004004646A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4036440B2 (ja) * 2002-03-29 2008-01-23 東洋合成工業株式会社 新規な感光性化合物及び感光性樹脂並びに感光性組成物
AU2007237861B2 (en) * 2006-04-18 2012-05-10 Council Of Scientific And Industrial Research Novel antibacterial compounds
GB0609617D0 (en) * 2006-05-16 2006-06-21 Astrazeneca Ab Process & intermediate
US20080242597A1 (en) * 2006-10-20 2008-10-02 Kun Liu Antibiotic compounds
US20080132500A1 (en) * 2006-10-20 2008-06-05 Kun Liu Antibiotic compounds
WO2022149618A1 (ja) * 2021-01-06 2022-07-14 中外製薬株式会社 酸性官能基のアルキル化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1242052C (zh) 1998-07-16 2006-02-15 布里斯托尔-迈尔斯斯奎布公司 诺卡氏菌的生物纯培养物
WO2000014100A1 (en) 1998-09-04 2000-03-16 Bristol-Myers Squibb Company Nocathiacin antibiotic derivatives prepared by microbial biotransformation
US6287827B1 (en) 1999-05-05 2001-09-11 Bristol-Myers Squibb Company Halo- or hydroxy-substituted nocathiacin antibiotics
US20020055465A1 (en) 2000-08-14 2002-05-09 Wenying Li Nocathiacin antibiotics prepared by biotransformation or chemical methods
US20020065219A1 (en) * 2000-08-15 2002-05-30 Naidu B. Narasimhulu Water soluble thiazolyl peptide derivatives

Also Published As

Publication number Publication date
WO2004004646A3 (en) 2004-09-16
AU2003247783A1 (en) 2004-01-23
US7022667B2 (en) 2006-04-04
US20040018963A1 (en) 2004-01-29
WO2004004646A2 (en) 2004-01-15
JP2005536492A (ja) 2005-12-02
BR0312550A (pt) 2005-04-26
CA2491074A1 (en) 2004-01-15
EP1531854A2 (en) 2005-05-25
EP1531854A4 (en) 2006-06-28
MXPA05000140A (es) 2005-04-11

Similar Documents

Publication Publication Date Title
CN1189471C (zh) 膦酰基头孢烯化合物
CN1310907C (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1241931C (zh) 大环内酯抗感染药物
CN1052984C (zh) 新的红霉素衍生物、其制备方法及其作为药物的应用
CN1009930B (zh) 含喹啉羧酸衍生物的药物组合物的制备方法
CN1119647A (zh) 6元含氮杂芳基噁唑烷酮
CN1143961A (zh) 噁唑烷酮衍生物和含有它们的药物组合物
CN1330660A (zh) 环四肽化合物及其用途
CN87104590A (zh) 头孢菌素化合物及其制备和抗菌剂
CN87107938A (zh) 3-吡咯烷基硫代-1-氮杂双环[3，2，0]庚-2-烯-2-甲酸化合物及其制备方法
CN1250544C (zh) 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法
CN1108657A (zh) 雪花胺衍生物、其制备方法及其作为药物的用途
CN1251836A (zh) 单环β－内酰胺类抗生素衍生物的中间体的制备方法
CN1054980A (zh) 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物，它们的制备方法以及它们的中间体
CN1678340A (zh) O－衍化诺卡硫星衍生物
CN1305462A (zh) 具有止喘、抗变态反应、抗炎、免疫调节和神经保护作用的新的1,5和3－o－取代1h－吲唑类化合物,其制备方法以及作为药物的应用
CN1126212A (zh) 喜树碱衍生物及其制造方法和抗肿瘤剂
CN1922190A (zh) 3－吡啶甲基头胞化合物
CN1043939A (zh) 制备抗菌素太可普劳宁的63-羧酸酰胺的方法
CN1184221C (zh) 有7－(7－氨甲基－5－氮杂螺[2,4]庚烷)取代基的新喹啉羧酸衍生物及其制备方法
CN1202173A (zh) 表鬼臼毒素2″,3″二脱氧糖苷的新型胺衍生物,其制备方法其作为药物的应用及其抗癌治疗的应用
CN1031192C (zh) 3′-脱氨基-4′-脱氧-4′-氨基-8-氟蒽环苷类的制备方法
CN1150429A (zh) 头孢菌素化合物及其制备方法
CN1192999C (zh) 用作葡萄糖－6－磷酸移位酶抑制剂的芳族二酮基衍生物
CN1688589A (zh) β－内酰胺酶抑制剂前体药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication